IRIS

In 2007, we published an opinion document to review the role of pegvisomant (PEG) in the treatment of acromegaly. Since then, new evidence emerged on the biochemical and clinical effects of PEG and on its long-term efficacy and safety.

Pegvisomant in acromegaly: an update / Giustina, A; Arnaldi, G; Bogazzi, F; Cannavò, S; Colao, Annamaria; De Marinis, L; De Menis, E; Degli Uberti, E; Giorgino, F; Grottoli, S; Lania, A. G; Maffei, P; Pivonello, Rosario; Ghigo, E.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - (2017). [10.1007/s40618-017-0614-1]

Pegvisomant in acromegaly: an update

COLAO, ANNAMARIA;PIVONELLO, ROSARIO;
2017

Abstract

In 2007, we published an opinion document to review the role of pegvisomant (PEG) in the treatment of acromegaly. Since then, new evidence emerged on the biochemical and clinical effects of PEG and on its long-term efficacy and safety.
2017
Pegvisomant in acromegaly: an update / Giustina, A; Arnaldi, G; Bogazzi, F; Cannavò, S; Colao, Annamaria; De Marinis, L; De Menis, E; Degli Uberti, E; Giorgino, F; Grottoli, S; Lania, A. G; Maffei, P; Pivonello, Rosario; Ghigo, E.. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - (2017). [10.1007/s40618-017-0614-1]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/666112
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 67
  • ???jsp.display-item.citation.isi??? 56
social impact